The role of VEGF SNPs in clinical outcomes in patients with gastric cancer was previously studied retrospectively, producing inconclusive results, as there was selection bias for enrollment and a lack of uniform criteria for primary end points [30–34]. The gene discussed is VEGFA; the disease is gastric cancer.